HER2-negative Breast Cancer Patients With Brain Metastases
1 clinical trials · Condition
◉ Watch HER2-negative Breast Cancer Patients With Brain Metastases
| Record | Firm | Date |
|---|---|---|
| A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases (NCT06764940) | Biostar Pharma, Inc. | 2025-07-14 |
Track HER2-negative Breast Cancer Patients With Brain Metastases automatically
Every clearance here is in the API, with alerts when new ones post.